MEDX.US Horizon Kinetics Medical ETF
- Total assets
- 17.9M
- Expense ratio
- 0.85%
- Dividend yield
- 1.07%
- 1-year return
- +18.86%
- Holdings
- 30
- Since
- 1999
Fund data as reported by the issuer, updated Nov 17, 2026. Total assets are in the fund's base currency.
What does MEDX.US invest in?
- Mostly US stocks (72.2%)
- Largest sector: Healthcare (100.0%)
- Largest region: North America (79.9%)
- Top 3 holdings: 37.5% of the fund
Asset allocation
- US stocks 72.2%
- Non-US stocks 18.1%
- Cash 8.0%
- Other 0.2%
Top holdings
- Eli Lilly and Company 21.14%
- AbbVie Inc 9.78%
- Novartis AG ADR 6.54%
- Johnson & Johnson 5.99%
- Amgen Inc 4.95%
Horizon Kinetics Medical ETF performance
Sharpe ratio 0.70- This year
- +15.34%
- 1 year
- +18.86%
- 3 years
- +14.53%
- 5 years
- +6.68%
Volatility 18.2% over 1 year and 16.2% over 3 years. Moderate, similar to a broad stock index.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
MEDX.US price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
About Horizon Kinetics Medical ETF
The fund is an actively-managed exchange-traded fund ("ETF") that pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes in common stocks, convertible securities, warrants and other equity securities having the characteristics of common stocks of U.S. and foreign companies engaged in medical research, pharmaceutical and medical technology industries and related technology industrie…
Full fund profileHorizon Kinetics Medical ETF top holdings
70.0% of the fund| Holding | Sector | Country | Weight |
|---|---|---|---|
| Eli Lilly and Company LLY.US | Healthcare | United States | 21.14% |
| AbbVie Inc ABBV.US | Healthcare | United States | 9.78% |
| Novartis AG ADR NVS.US | Healthcare | United States | 6.54% |
| Johnson & Johnson JNJ.US | Healthcare | United States | 5.99% |
| Amgen Inc AMGN.US | Healthcare | United States | 4.95% |
| AstraZeneca PLC AZN.LSE | Healthcare | United Kingdom | 4.92% |
| Alkermes Plc ALKS.US | Healthcare | United States | 4.63% |
| Merck & Company Inc MRK.US | Healthcare | United States | 4.58% |
| Bristol-Myers Squibb Company BMY.US | Healthcare | United States | 4.01% |
| Biogen Inc BIIB.US | Healthcare | United States | 3.41% |
The 10 largest of 30 holdings.
MEDX.US sector exposure
- Healthcare100.0%
Share of the stocks in the fund.
MEDX.US regional exposure
- North America79.9%
- Europe Developed10.9%
- United Kingdom9.2%
Share of the stocks in the fund.
Company size
Average market cap 181B- Mega cap36.6%
- Big cap36.7%
- Medium cap8.0%
- Small cap6.1%
- Micro cap4.1%
Horizon Kinetics Medical ETF fund profile
- Fund name
- Horizon Kinetics Medical ETF
- Ticker
- MEDX.US
- Exchange
- USA Stocks
- Issuer
- Horizon Kinetics
- Index tracked
- -
- Category
- Healthcare Equity
- Inception date
- Sep 30, 1999
- Trading currency
- USD
- Expense ratio
- 0.85%
About Horizon Kinetics Medical ETF
The fund is an actively-managed exchange-traded fund ("ETF") that pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes in common stocks, convertible securities, warrants and other equity securities having the characteristics of common stocks of U.S. and foreign companies engaged in medical research, pharmaceutical and medical technology industries and related technology industries. The fund is non-diversified.